Skip to main content
. 2012 Sep 6;120(22):4285–4291. doi: 10.1182/blood-2012-07-438408

Figure 1.

Figure 1

Conditioning schema. Patients 1 and 2 did not receive ATG. Patients 1 to 10 received tacrolimus and patients 11 to 17 received sirolimus. Patients 15 to 17 received G-CSF–primed bone marrow (see “Protocol evolution”).

HHS Vulnerability Disclosure